CMENEUTRAL

Current Ratio

1.02x

Updated 102h ago

Sector Performance

34th percentile

CME

1.02x

Sector Median

1.20x

Sector Avg

2.57x

📊

Deep Analysis

The current ratio of 1.02x means CME has $1.02 in short-term assets for every $1.00 of short-term liabilities, indicating a very thin liquidity buffer.

This sits below the sector median of 1.20x, placing CME in the 34th percentile among its peers—meaning about two-thirds of similar companies have a higher ratio. No trend data is available: both year-over-year and quarter-over-quarter changes are listed as N/A, and only a single data point exists. Without a trend, investors cannot assess whether liquidity is improving or deteriorating, so the risk lies entirely in the current low level. The combination of a below-median ratio and absent trend data suggests limited room for error if short-term obligations suddenly rise, creating a modest liquidity risk. This metric contradicts a NEUTRAL verdict because it flags a potential weakness that could warrant a more cautious stance, though the overall view remains neutral based on other factors.

Frequently Asked Questions

What does the Current Ratio tell investors about CME?

Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.

How is the Current Ratio calculated?

Current Ratio is calculated as: Current Assets / Current Liabilities.

Who are CME's closest peers by Current Ratio?

The closest peers by Current Ratio include: KEY (0.42x), GEN (0.40x), CHTR (0.40x), USB (0.40x), DRI (0.39x).

The Formula

Current Assets / Current Liabilities

Why It Matters

Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.

Advertisement

Master CME's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full CME research report

Free account — no credit card

CME

1.02x

Sector Median

1.20x

Sector Avg

2.57x

How CME's Current Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.